Fixed-dose combinations of drugs versus single drug formulations for treating pulmonary tuberculosis

  • Protocol
  • Intervention

Authors

  • Carmen R Gallardo,

    Corresponding author
    1. Hospital Universitari Sant Joan d´Alacant, Preventive Medicine and Healthcare Quality Service, Alicante, Alicante, Spain
    • Carmen R Gallardo, Preventive Medicine and Healthcare Quality Service, Hospital Universitari Sant Joan d´Alacant, Ctra. Nacional. 332 Alicante-Valencia, s/n, Alicante, Alicante, 03550, Spain. carmengrosa@yahoo.fr.

    Search for more papers by this author
  • David Rigau Comas,

    1. CIBER Epidemiología y Salud Pública (CIBERESP), Spain, Iberoamerican Cochrane Centre. Institute of Biomedical Research (IIB Sant Pau), Barcelona, Spain
    Search for more papers by this author
  • Angélica Valderrama Rodríguez,

    1. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona, Clinical of Pharmacology Department, Barcelona, Spain
    Search for more papers by this author
  • Marta Roqué i Figuls,

    1. CIBER Epidemiología y Salud Pública (CIBERESP), Spain, Iberoamerican Cochrane Centre, Institute of Biomedical Research (IIB Sant Pau), Barcelona, Barcelona, Catalunya, Spain
    Search for more papers by this author
  • Lucy Anne Parker,

    1. Universidad Miguel Hernández de Elche, CIBER Epidemiología y Salud Pública (CIBERESP), Department of Public Health, History of Science and Gynaecology, Alicante, Spain
    Search for more papers by this author
  • Joan Caylà,

    1. Agència de Salut Pública de Barcelona (IIB-Sant Pau, CIBERESP), Barcelona, Spain
    Search for more papers by this author
  • Xavier Bonfill Cosp

    1. CIBER Epidemiología y Salud Pública (CIBERESP), Spain - Universitat Autònoma de Barcelona, Iberoamerican Cochrane Centre - Institute of Biomedical Research (IIB Sant Pau), Barcelona, Catalonia, Spain
    Search for more papers by this author

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To compare the efficacy, safety and acceptability of antituberculous regimens given as fixed-dose combinations compared to single-drug formulation for treating newly diagnosed pulmonary TB.